Škof, E. (2021). Experience with olaparib in the treatment of recurrent ovarian epithelial cancer with mutations in the BRCA 1 and BRCA 2 genes. Onkologija : A Medical-Scientific Journal, 25(1), 12-16. https://doi.org/10.25670/oi2021-002on